NLS Pharmaceutics Ltd (NLSP)
0.1533
0.00 (0.00%)
USD |
NASDAQ |
May 17, 16:00
0.153
0.00 (0.00%)
After-Hours: 20:00
NLS Pharmaceutics Free Cash Flow: -9.684M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -9.684M |
| June 30, 2023 | -13.51M |
| December 31, 2022 | -13.88M |
| June 30, 2022 | -12.87M |
| December 31, 2021 | -14.98M |
| June 30, 2021 | -9.930M |
| Date | Value |
|---|---|
| December 31, 2020 | -0.7294M |
| June 30, 2020 | -1.436M |
| December 31, 2019 | -0.19M |
| June 30, 2019 | -0.3311M |
| December 31, 2018 | -2.733M |
Free Cash Flow Range, Past 5 Years
-14.98M
Minimum
Dec 2021
-0.19M
Maximum
Dec 2019
-7.753M
Average
-9.807M
Median
Free Cash Flow Benchmarks
| AC Immune SA | -48.92M |
| CRISPR Therapeutics AG | -169.05M |
| Addex Therapeutics Ltd | -8.908M |
| Molecular Partners AG | -66.61M |
| MoonLake Immunotherapeutics | -48.91M |
Free Cash Flow Related Metrics
| Free Cash Flow Yield | -154.7% |